Description

Cravihenz 40 Tablet is a medicine that contains the active ingredient Megestrol Acetate. Megestrol Acetate is a synthetic progesterone-like hormone that is commonly used to manage certain types of cancer and as a palliative treatment for advanced breast or endometrial cancer. Cravihenz 40 Tablet is specifically formulated with a dosage strength of 40mg. It is essential to follow the prescribed dose and frequency strictly. The tablet acts by interfering with the production or actions of certain hormones in the body, thereby inhibiting the growth of cancer cells. It may also alleviate symptoms associated with cancer, such as loss of appetite, weight loss, and nausea. Patients should consult their healthcare provider for complete information about dosage, potential side effects, and any other precautions associated with Cravihenz 40 Tablet.

Additional information